Khamis Faryal, Al-Zakwani Ibrahim, Molai Mariya, Mohsin Jalila, Al Dowaiki Samta, Al Bahrani Maher, Petersen Eskild
Infectious Diseases Unit, Department of Internal Medicine, Royal Hospital, Muscat, Oman.
Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
IJID Reg. 2022 Aug 4;4:165-170. doi: 10.1016/j.ijregi.2022.08.001. eCollection 2022 Sep.
The incidence of carbapenem-resistant Enterobacteriaceae (CRE) has increased in the last two decades, causing significant morbidity and mortality. Our study investigated the factors associated with mortality from CRE bloodstream infection in a single center in Oman.
Data from adult patients with CRE bacteremia, over a 10-year period, were retrospectively collected. Demographic and clinical characteristics were compared according to intensive care unit (ICU) admission status and mortality. A logistic regression model was used to evaluate factors associated with mortality.
169 cases of CRE bacteremia were identified, of whom 93 (55%) required ICU admission and 96 (56.8%) died. Patients who required ICU care were more likely to require organ transplant (15% vs 4.0%; = 0.02), be on immunosuppressants (31% vs 17%; = 0.035), be transferred from other hospitals (40% vs 14%; < 0.001), be colonized with CRE (73% vs 43%; < 0.001), have vascular lines (85% vs 42%; < 0.001), be on mechanical ventilation (91% vs 9.2%; < 0.001), require a longer stay (37 vs 17 days; < 0.001), and have increased mortality (80% vs 29%; < 0.001). In the multivariate analysis, mechanical ventilation (adjusted odds ratio (aOR) 15.3; 95% confidence interval 5.39-43.2; < 0.001) and prior use of the broad-spectrum antibiotics meropenem ( = 0.01) and piperacillin/tazobactam ( = 0.026) were associated with CRE mortality.
CRE bacteremia carries a high mortality rate in patients requiring ICU care. Implementation of infection control measures and antimicrobial stewardship programs are essential in reducing the rates of CRE BSI.
耐碳青霉烯类肠杆菌科细菌(CRE)的发病率在过去二十年中有所上升,导致了显著的发病率和死亡率。我们的研究调查了阿曼一个单一中心中与CRE血流感染死亡率相关的因素。
回顾性收集了10年间成年CRE菌血症患者的数据。根据重症监护病房(ICU)入住情况和死亡率比较人口统计学和临床特征。使用逻辑回归模型评估与死亡率相关的因素。
共确定了169例CRE菌血症病例,其中93例(55%)需要入住ICU,96例(56.8%)死亡。需要ICU护理的患者更有可能需要器官移植(15%对4.0%;P = 0.02)、使用免疫抑制剂(31%对17%;P = 0.035)、从其他医院转入(40%对14%;P < 0.001)、被CRE定植(73%对43%;P < 0.001)、有血管通路(85%对42%;P < 0.001)、接受机械通气(91%对9.2%;P < 0.001)、住院时间更长(37天对17天;P < 0.001)以及死亡率更高(80%对29%;P < 0.001)。在多变量分析中,机械通气(调整后的优势比(aOR)为15.3;95%置信区间为5.39 - 43.2;P < 0.001)以及先前使用广谱抗生素美罗培南(P = 0.01)和哌拉西林/他唑巴坦(P = 0.026)与CRE死亡率相关。
在需要ICU护理的患者中,CRE菌血症的死亡率很高。实施感染控制措施和抗菌药物管理计划对于降低CRE血流感染率至关重要。